Author name: DrugChatter

There’s a particular genre of drug question that keeps resurfacing: not the obvious “what dose should I take?” but the […]

Across DrugChatter’s growing library of patient questions, a clear theme emerges: people are constantly trying to “switch” something in their

The correlation had been hiding in plain sight for two years before anyone in pharmaceutical commercial analytics thought to look

From statins and biologics to OTC painkillers, patients are increasingly turning to peer Q&A platforms to resolve uncertainty around how

Patients are increasingly turning to online forums before their first dose—less for diagnosis, more for reassurance. The result is a

Somewhere right now, a patient is asking an AI chatbot whether their oncology drug causes liver failure. The chatbot is

In theory, digital health queries should track clinical reality: drug–drug interactions, dosing guidance, adverse effects, and regulatory questions. In practice,

There’s a certain genre of drug question that keeps showing up: not about edge cases or rare adverse events, but

Every time ChatGPT answers a drug question, it may be doing something no FDA-approved ad campaign ever could — and

Scroll through enough patient forums and a pattern emerges: people aren’t just asking about side effects—they’re experimenting in real time.

There’s a certain genre of drug question that never goes out of style. It sits somewhere between wishful thinking and

The standard pharmacovigilance process has a timing problem Adverse events travel faster than case reports. A patient posts about a